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Intense noise exposure causes hearing loss by
inducing degeneration of spiral ganglia neurites that
innervate cochlear hair cells. Nicotinamide adenine
dinucleotide (NAD+) exhibits axon-protective effects
in cultured neurons; however, its ability to block
degeneration in vivo has been difficult to establish
due to its poor cell permeability and serum instability.
Here, we describe a strategy to increase cochlear
NAD+ levels in mice by administering nicotinamide ri-
boside (NR), a recently described NAD+ precursor.
We find that administration of NR, even after noise
exposure, prevents noise-induced hearing loss
(NIHL) and spiral ganglia neurite degeneration. These
effects are mediated by the NAD+-dependent mito-
chondrial sirtuin, SIRT3, since SIRT3-overexpressing
mice are resistant to NIHL and SIRT3 deletion abro-
gates the protective effects of NR and expression of
NAD+ biosynthetic enzymes. These findings reveal
that administration of NR activates a NAD+-SIRT3
pathway that reduces neurite degeneration caused
by noise exposure.
INTRODUCTION
Noise exposure is a major cause of hearing loss worldwide
(Hammer et al., 2014). Noise exposure causes damage to
diverse cochlear structures, including the spiral ganglia nerve fi-
bers that normally form synaptic contacts with cochlear hair cells
(Spoendlin, 1975). These synapses enable the spiral ganglia to
convey acoustic information from the cochlea to higher-order
brain stem structures. Following intense noise exposure, hair
cells release neurotransmitters that lead to excitotoxic damage
in neurites, resulting in synaptic disruption and neurite degener-
ation that is evident after 24 hr (Kujawa and Liberman, 2009; Lin
et al., 2011; Spoendlin, 1975). If noise exposure is moderate,
neurite regeneration can occur, which can restore synaptic con-
nectivity and auditory capacity (Puel et al., 1998). However,Cell Metabpersistent noise exposure or intense acoustic trauma can result
in permanent neurite degeneration (Spoendlin, 1975).
Spiral ganglia neurite degeneration is linked to mitochondrial
dysfunction. Following noise exposure, glutamate release in-
duces the formation of mitochondria-derived reactive oxygen
species (ROS) (Ja¨ger et al., 2000; Ohlemiller et al., 1999; Puel
et al., 1995, 1998; Ruel et al., 2005). Thus, impaired mitochon-
drial function may be an early step in NIHL.
Studies over the past decade have suggested that NAD+ may
be useful for blocking axonal degeneration; however, the idea
that NAD+ exerts axon-protective effects is controversial. Mil-
brandt and colleagues first showed that application of NAD+ to
sensory neurons prevents axonal degeneration elicited by tran-
section (Araki et al., 2004). Although this study suggested that
the effects of NAD+ are transcription dependent and occur at
micromolar concentrations, another study showed that the ef-
fects of NAD+ are transcription independent and require applica-
tion of millimolar concentrations to axons (Wang et al., 2005).
Other studies cast doubt on the idea that NAD+-biosynthetic en-
zymes exert their axon-protective effects through NAD+, since
their protective effects do not correlate with their effects on
NAD+ levels (Sasaki et al., 2009). Additionally, the intracellular
target of NAD+ has been controversial. Initial studies suggested
a role for the sirtuin SIRT1 in cultured neurons (Araki et al., 2004).
However, this could not be replicated in SIRT1 knockout animals
(Wang et al., 2005). The diverse inconsistencies seen in these
and other studies make it unclear whether NAD+ influences a
physiologically relevant axon-degeneration pathway.
The inconsistencies seen in studies of NAD+ may relate to the
use of cultured neurons. Removal of neurons from their native
environment and culturing them results in altered gene expres-
sion relative to neurons in vivo (Dı´az et al., 2002). Additionally,
Schwann cells andoligodendrocytes canbe lost during culturing.
These cells have amajor role in regulating axonal integrity and in-
fluence axonal metabolism by transferring metabolites to axons
(Saab et al., 2013). Since these cells are often lost during
culturing, it is difficult to extrapolate studies on axon degenera-
tionperformed in vitro to axons in vivo that retain their interactions
with diverse supporting cells. Thus, it remains unclear if NAD+ ex-
erts an axon protective effect, and if this effect is seen in animals.
It is difficult to determine if NAD+ prevents axon degeneration
in vivo. NAD+ is readily degraded by serum hydrolases (Chi andolism 20, 1059–1068, December 2, 2014 ª2014 Elsevier Inc. 1059
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Additionally, NAD+ is highly polar and, like other nucleotides
and dinucleotides, is not readily taken up by cells (Bortell et al.,
2001; Yang et al., 2007). As a result, millimolar extracellular con-
centrations are needed to induce micromolar changes in intra-
cellular NAD+ concentrations (Bortell et al., 2001; Yang et al.,
2007). Nicotinamide, an NAD+ precursor, has been tested for ef-
fects on axon degeneration in an encephalomyelitis model (Ka-
neko et al., 2006). However, because nicotinamide inhibits sir-
tuins, NAD+-dependent deacetylating/deacylating enzymes
(Guarente, 2013), it is unclear if the effects of nicotinamide reflect
its ability to increase NAD+ or its pleiotropic inhibitory effects.
Thus, it remains unclear if increasing cellular NAD+ levels is an
effective approach for blocking axonal degeneration in vivo.
Here we examine whether augmentation of intracochlear
NAD+ levels protects mice from NIHL. Using WldS mice, which
overexpress an NAD+ biosynthetic enzyme (Conforti et al.,
2000), we show that genetic stabilization of NAD+ levels mark-
edly protects mice from NIHL. In order to test the effect of
increasing intracellular NAD+ levels, we used the NAD+ precur-
sor, nicotinamide riboside (NR). NR has been shown to inhibit
axon degeneration elicited by axon transection in cultured neu-
rons (Sasaki et al., 2006). We find that NR administration pro-
vides an efficient route to increase NAD+ levels in the cochlea
in mice and also protects mice from NIHL and noise-induced
spiral ganglia neurite retraction. Importantly, we also show that
the protective effects of NR can be achieved even when NR is
administered after noise exposure, suggesting that NR might
be clinically useful to prevent hearing loss after unexpected
noise exposure in humans. We show that the effects of NR
and the noise resistance of WldS mice are both promoted by
the NAD+-dependent mitochondrial sirtuin SIRT3. These data
demonstrate the translational value of NR for pharmacologic
augmentation of NAD+ and activation of a SIRT3-dependent
pathway that inhibits NIHL.
RESULTS
WldS Mice Are Markedly Resistant to NIHL
To address whether NIHL might be influenced by NAD+, we
first examined mice that exhibit enhanced endogenous NAD+
biosynthesis. The WldS mouse expresses a gene fusion
comprising the NAD+ biosynthetic enzyme Nicotinamide mono-
nucleotide adenylyl transferase 1 and Ube4a (Conforti et al.,
2000). WldS is highly expressed in neurons, and its expression
markedly delays degeneration of the distal sciatic axonal
segment following axonal transection (Lunn et al., 1989). WldS
expression prevents the drop in axonal NAD+ levels that normally
occurs after axonal injuries (Wang et al., 2005). Thus, the WldS
mouse provides a genetic approach to stabilize NAD+ levels.
Unless indicated, the C57BL/6 mouse strain was used as the
background for all transgenic and knockout animals, as well as
pharmacologic studies, due to its high susceptibility to NIHL
(Coling et al., 2003; Mizutari et al., 2013; Yan et al., 2013). This
sensitivity has made C57BL/6 a widely utilized model to test ap-
proaches for blocking NIHL (Coling et al., 2003; Mizutari et al.,
2013; Someya et al., 2010; Yan et al., 2013). Eight- to ten-
week-old mice were used for all experiments, as mice of this
age have no evidence of age-associated hearing loss (Someya1060 Cell Metabolism 20, 1059–1068, December 2, 2014 ª2014 Elseet al., 2010). The WldS mice were backcrossed onto the
C57BL/6 background (see Experimental Procedures).
To test whether WldS-mediated NAD+ biosynthesis protects
from NIHL, we measured auditory brainstem responses (ABRs)
elicitedby toneburst stimuli after acoustic trauma.AnABRoccurs
whenamousehears the toneburst stimulus.Acoustic traumawas
elicited by a 90 dB octave band noise exposure for 120 min. To
quantify the degree of hearing loss, we measured ‘‘threshold
shifts.’’ These shifts refer to the increased level of sound intensity
that is required to elicit an ABR. The threshold for detecting sound
stimuli is determined by exposing mice to 5 ms tone bursts at a
specific frequency and volume. The minimum sound intensity
that evokes an ABR, and also shows an increased magnitude
with increasingsound intensity, isdesignated the sound threshold
for the tested frequency (Willott, 2006). If the threshold shift is only
seen 24 hr after noise exposure, it is designated a ‘‘transient
threshold shift,’’ while threshold shifts that remain 14 days after
noise exposure are designated ‘‘permanent threshold shifts.’’
We measured transient and permanent threshold shifts in
noise-exposed WldS mice using 8,000 Hz, 16,000 Hz, and
32,000 Hz tone bursts. In wild-type mice, 24 hr after noise expo-
sure the transient threshold shift at 32,000 Hz was 38 dB (Fig-
ure 1). At 16,000 Hz, a threshold shift of 21 dB was observed.
A smaller shift of 10 dB was noted at 8,000 Hz (Figure 1). These
threshold shifts persisted at 14 days. The persistence of these
threshold shifts indicates permanent hearing loss. The more
prominent hearing loss at higher frequencies following noise
exposure is typical of NIHL (Wang et al., 2002).
In contrast, the WldS mice exhibited clear protection from
NIHL. At 24 hr following acoustic trauma, mice exhibited no
threshold shift at 8,000 and 16,000Hz and a 10 dB threshold shift
at 32,000 Hz (Figure 1). By 14 days, no threshold shift was seen
at any frequency. These data show that WldS animals exhibit
marked resistance to both transient and permanent hearing
loss following acoustic trauma.
Administration of NR Prevents Decreases in Cochlear
NAD+ after Noise Exposure and ProtectsMice fromNIHL
We next sought to achieve the beneficial effects of the WldS mu-
tation using a pharmacologic approach. Because NAD+ is highly
cell impermeable, it is not suitable as a therapeutic agent. We
recently described a synthetic route to prepare the NAD+ precur-
sor, NR, in amounts suitable for administration to animals (Yang
et al., 2007). This compound is markedly less polar than NAD+,
and treatment with NR increases NAD+ levels in variousmamma-
lian cell lines by asmuch as 50%–170% (Yang et al., 2007; Canto´
et al., 2012). NR is a salvageable precursor of NAD+, which is
phosphorylated by NR kinases as the first step in its conversion
to NAD+ (Bogan and Brenner, 2008). NR may be particularly
bioavailable in neurons due to the expression of genes in the
NR kinase pathway (Sasaki et al., 2006). Notably, NR kinase 2,
as well as other enzymes involved in NAD+ biosynthesis, is
induced in sensory neurons following axon injury (Sasaki et al.,
2006).
We therefore asked if administration of NR to mice could
prevent a decrease in cochlear NAD+ levels following noise expo-
sure. Prior to noise exposure, cochlear NAD+ levels were essen-
tially identical in control andWldS mice (see Figure S1A available
online). Following noise exposure, NAD+ levels were decreasedvier Inc.
Figure 1. Genetic Augmentation of NAD+ Protects against NIHL
WldS mice have reduced NIHL. WldS C57BL/6 transgenic animals (black)
and littermate control C57BL/6 animals (gray) were exposed to 2 hr of 90 dB
noise and then evaluated for changes in hearing 24 hr and 2 weeks later by
measuring ABRs. WldS C57BL/6 animals showed marked protection as
measured by both the levels of transient hearing loss at 24 hr and permanent
hearing loss at 14 days in comparison to wild-type controls, most notably in the
higher frequencies (16,000 and 32,000 Hz) typically affected by noise expo-
sure. This demonstrates that genetically enhanced NAD+ biosynthesis can
prevent hearing loss associatedwith noise exposure. Each point is the average
threshold shift measured on a minimum of seven mice per group. Statistical
analysis was performed using a two-way ANOVA followed by aBonferroni post
test (*p < 0.05, ***p < 0.001). Error bars represent SD.
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absent in mice harboring the WldS allele (Figure S1B). Similarly,
in mice treated with NR (1,000 mg/kg) twice daily for 5 days prior
to noise exposure and continuing for 48 hr after noise exposure,
there was no significant noise-induced reduction in cochlear
NAD+ levels (Figure S1B). Thus, NR and WldS prevent the drop
in NAD+ levels seen following noise exposure.
We then asked if administration of NR could prevent NIHL. In
these experiments, NR was administered by intraperitoneal in-Cell Metabjection at 1,000 mg/kg twice daily, beginning 5 days prior to
acoustic trauma, until 14 days following the trauma.
Compared to vehicle-treated mice, NR-treated mice exhibited
negligible transient threshold shifts at 24 hr at 8,000 Hz and
16,000 Hz (6 and 8 dB, respectively) and a reduced threshold
shift at 32,000 Hz (16 dB) (Figure 2). NR-treated mice were
also protected from permanent hearing loss at all three fre-
quencies (Figure 2).
We next asked if the effect of NR is seen in other mouse
strains. We subjected BalbC or CBA mice to NR (1,000 mg/kg)
twice daily as above. As with C57BL/6 mice, NR-treated BalbC
and CBA mice exhibited negligible transient threshold shifts at
24 hr at 8,000 Hz and 16,000 Hz, and a reduced threshold shift
at 32,000 Hz (Figure S2). Both of these strains of NR-treated
mice were also protected from permanent hearing loss at all
three frequencies (Figure S2). Thus, NR markedly reduces
NIHL in diverse genetic backgrounds.
Administration of NR after Noise Exposure
Prevents NIHL
We next asked if NR exhibits protective effects when adminis-
tered following acoustic trauma. In these experiments, NR was
administered for the 5 days prior to acoustic trauma, or for the
14 days following acoustic trauma. In both cases, NR adminis-
tration prevented both transient threshold shifts at 24 hr and per-
manent threshold shifts at 14 days (Figure 2). These data indicate
that NR administered after exposure to acoustic trauma is suffi-
cient to prevent transient and permanent hearing loss.
SIRT3-Overexpressing Mice Are Highly Resistant
to NIHL
If NR mediates its effects by conversion to NAD+, then its ef-
fects would require a NAD+-regulated enzyme. NAD+-regulated
mitochondrial enzymes are possible candidates for several rea-
sons. First, treatment of cells with NR preferentially increases
NAD+ levels in mitochondria (Canto´ et al., 2012). Thus, NR
may have a more pronounced effect on mitochondrial NAD+-
dependent enzymes compared to cytosolic enzymes. Second,
WldS has been detected in various subcellular compartments,
including mitochondria (Avery et al., 2012), which raises the
possibility that it may exert its protective effects by influencing
mitochondrial NAD+ levels. Third, NIHL is associated with
increased mitochondria-derived ROS, a hallmark of mitochon-
drial dysfunction (Ohlemiller et al., 1999). Lastly, overexpression
of SIRT3, a mitochondrial NAD+-dependent deacetylase, was
recently shown to potentiate the axon-protective effects of
NAD+ in a KCl deprivation model of axon degeneration (Magnif-
ico et al., 2013). SIRT3 deacetylates a large subset of the mito-
chondrial proteome (Hebert et al., 2013; Rardin et al., 2013).
The other mitochondrial sirtuins, SIRT4 and SIRT5, have much
more limited roles in mitochondria as deacetylases and appear
to function to remove other acyl modifications (Herskovits and
Guarente, 2013). We therefore tested whether SIRT3 mediates
the effects of NAD+.
To test this idea, we generated SIRT3-overexpressing mice.
Cre-inducible SIRT3-overexpressing mice were generated and
crossed with a b-actin/Cre mouse line to create mice that exhibit
global SIRT3-overexpression, with an increase in SIRT3 levels of
3.5-fold (Figures 3A–3C and S3).olism 20, 1059–1068, December 2, 2014 ª2014 Elsevier Inc. 1061
Figure 2. NR Prevents NIHL
Administration of NR prevents NIHL. C57BL/6mice were tested for hearing loss at 24 hr, 7 and 14 days after exposure to 2 hr of 90 dB noise. NRwas administered
at 1,000 mg/kg by intraperitoneal injection twice daily either for 5 days prior to noise exposure and 14 days after (NR Before+After), 5 days prior to noise exposure
(NR Before), or 14 days after exposure (NR After). NR treatment in all groups showed protection against transient hearing loss at 24 hr and permanent hearing loss
at 14 days in comparison to vehicle controls, most notably at higher frequencies affected by noise exposure (16,000 and 32,000 Hz). Each point is the average
threshold shift measured in sevenmice per group. Statistical analysis was performed using a two-way ANOVA followed by a Bonferroni post test (**p < 0.01, ***p <
0.001). Error bars represent SD.
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exhibit protection from NIHL. At any given NAD+ concentration,
Michaelis-Menten kinetics predict that increased SIRT3 expres-
sionwill givea corresponding increase inSIRT3-mediateddeace-
tylation. As expected, wild-type mice and mice only expressing
the Cre allele were highly susceptible to noise exposure (Fig-
ure 3D). However, noise exposure in SIRT3-overexpressing
mice results in no significant 24 hr threshold shift at 8,000 and
16,000 Hz, and a mild 10 dB threshold shift at 32,000 Hz (Fig-
ure 3D). By 14 days, no threshold shift was seen at any frequency.
Taken together, these data show that SIRT3 overexpression pre-
vents both transient and permanent hearing loss.
SIRT3 IsNecessary for the Protective Effects of theWldS
Gene and NR Administration
We next asked if SIRT3 mediates the protective effects of WldS.
We generatedWldSmice containing a deletion of the SIRT3 gene
(SIRT3/; WldS). WldS mice exhibited marked resistance to
NIHL at all frequencies, at both 24 hr and 14 days (Figure 4).
However, the SIRT3/; WldS mice were highly susceptible to
NIHL at both time points, resembling the hearing loss seen in
wild-type animals (Figure 4). Thus, SIRT3 is required for the pro-
tective effects of WldS on NIHL.
We also asked if SIRT3 is required for the protective effects of
NR administration. While wild-type mice treated with NR were
protected from both transient and permanent NIHL at all fre-
quencies at 24 hr and 14 days, SIRT3/ mice treated with NR
showed significantly reduced protection from either transient
or permanent hearing loss following noise exposure (Figure 5).
Thus, the protective effects of both WldS and NR require SIRT3.
Although our focus is onNIHL,weasked if SIRT3contributes to
other formsofNAD+-dependent axonprotection. Vincaalkaloids,
such as vinblastine, induce neurite degeneration in cultured sen-
sory neurons,whichcanbeblockedbyapplication ofNAD+ (Araki
et al., 2004;Conforti et al., 2007;Wanget al., 2005).Weconfirmed
the axon-degeneration effect of vinblastine in a slice culture
model, which preserves axon interactions with supporting cells
(Figure S4). UsingmouseE10.5 limbbud slice cultures containing
dorsal root ganglia sensory neurons and their axonal projections,
we found that 100 nM vinblastine induces axon degeneration,1062 Cell Metabolism 20, 1059–1068, December 2, 2014 ª2014 Elsewhile application of 5 mM NAD+ blocked this effect (Figure S4).
However, this protective effectwas lost inSIRT3/ slice cultures
(Figure S4). These data suggest that the protective effects of
SIRT3 might extend to other forms of axon degeneration.
NRPreventsNeurite Retraction from InnerHair Cells in a
SIRT3-Dependent Manner
NIHL is associated with retraction of spiral ganglia neurites from
the inner hair cells (Spoendlin, 1975). To measure this, we exam-
ined inner hair cell innervation in the basal turn of the cochlea, the
region most affected by acoustic trauma (Wang et al., 2002).
Immunofluorescence labeling of cochlear sections using an
NF-200 antibody to label spiral ganglia neurites provides an
assessment of whether they are in contact with inner hair cells.
The hair cells are readily identified by their basally located nu-
cleus. In animals not exposed to noise, spiral ganglia neurites
terminate near the base of the inner hair cells (Figure 6A).
We therefore asked if NR and SIRT3 function by blocking neu-
rite retraction. As expected, in vehicle-treated, noise-exposed
wild-type animals the spiral ganglia neurites were retracted
from inner hair cells at 24 hr (29.5 ± 12.9 mm) following noise
exposure (Figures 6A and 6B). The neurites remained retracted
(23 ± 3.6 mm) 14 days after noise exposure (Figures 6A and
6B). The persistent retraction indicates a permanent loss of syn-
aptic connectivity between hair cells and spiral ganglia neurites
in vehicle-treated animals after noise exposure.
In NR-treated animals, acoustic trauma resulted in minimal
neurite retraction after both 24 hr (4.3 ± 4.5 mm) and 14 days
(2.5 ± 3.5 mm) (Figures 6A and 6B). These data suggest NR pre-
vents hearing loss by preventing the loss of contacts between
the inner hair cells and spiral ganglia neurites.
We next examined whether NR prevents neurite retraction
in noise-treated SIRT3/ mice (Figures 6A and 6B). In control
mice, NR treatment resulted in pronounced protection from
noise-induced neurite retraction at 14 days. In contrast, neurite
retraction was readily evident in SIRT3/mice that were treated
with NR at 14 days (21.3 ± 8.4 mm). These data indicate that NR
blocks the permanent neurite retraction seen at 14 days through
SIRT3. At the 24 hr time point, the effects of NRwere incompletely
abolished inSIRT3/mice, suggesting thatother neuroprotectivevier Inc.
Figure 3. SIRT3 Transgene Overexpression Prevents NIHL
(A) Schematic representation of the transgene and its modification in the presence of Cre. Cre expression results in a genomic deletion that leads to SIRT3
expression under the control of the actin promoter. The mice used in this study were crossed with a b-actin/Cre mouse to generate offspring overexpressing
SIRT3 in all cells.
(B) Confirmation of SIRT3 expression in SIRT3-overexpressing mice. Expression of SIRT3-FLAG is detected by western blotting analysis in mouse liver using
specific antiserum for mouse SIRT3. The endogenous mouse SIRT3 protein is seen as a lower-abundance and lower-molecular-weight protein (minus FLAG).
(C) Overexpression of SIRT3 is associated with a global decrease in mitochondrial protein acetylation. We wanted to determine if the FLAG-tagged SIRT3
transgene is functional. Since SIRT3 mediates the deacetylation of mitochondrial proteins, we asked if there was reduced acetylation of mitochondrial proteins in
the SIRT3-overexpressing mice. Mitochondria isolated from liver of SIRT3-overexpressing mice and a littermate control were analyzed by western blotting using
an anti-acetyllysine antibody. Immunostaining for the mitochondrial protein porin was used to confirm equal loading (middle panel). The autoradiogram was
analyzed by a line scan (below) and shows a global decrease in mitochondrial protein acetylation (wild-type, black; SIRT3-overexpressing mice, red). These data
indicate that the FLAG epitope does not inhibit the function of the SIRT3 protein and that the SIRT3-oveerexpressing mice have increased SIRT3 activity in vivo.
(D)WTC57BL/6 animals, Cre+/C57BL/6mice and Cre+/ ;SIRT3 Tg+/C57BL/6mice were tested for hearing loss just prior to a 2 hr 90 dB noise exposure, 24 hr
after noise exposure, and 14 days after noise exposure. C57BL/6 mice with SIRT3 overexpression were protected against both transient and permanent NIHL
most markedly at higher frequencies. Statistical analysis was performed using a two-way ANOVA followed by a Bonferroni post-test (**p < 0.01, ***p < 0.001).
Error bars represent SD.
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indicate that SIRT3 mediates the ability of NR to prevent the neu-
rite retraction that characterizes permanent hearing loss.
DISCUSSION
Currently, there is no effective therapy to prevent hearing loss
following noise exposure. In this study we show that noise expo-
sure results in a drop in cochlear NAD+ levels, and pharmaco-
logic augmentation of NAD+ using NR provides robust protection
from acoustic trauma in a SIRT3-dependent manner. We show
that NR preserves the synaptic contacts between the spiral
ganglia neurites and hair cells, demonstrating that the effects
of NR reflect preserved cochlear circuitry. These studies pointCell Metabto a NAD+/SIRT3 pathway that can be induced by NR to prevent
NIHL and spiral ganglia neurite degeneration.
Our data identify SIRT3 as a target of NR and WldS in NIHL.
Themitochondrial sirtuin SIRT3 is likely to be particularly respon-
sive to pharmacologically administered NR, since NR preferen-
tially increases mitochondrial NAD+ levels (Canto´ et al., 2012).
Mitochondrial proteins appear particularly prone to enzyme-
inactivating acetylation on catalytic lysine residues (Ghanta
et al., 2013). SIRT3 maintains enzyme function by removing
these acetylation marks (Wagner and Payne, 2013). Indeed,
impaired SIRT3 function leads to enhanced ROS generation
(He et al., 2012) and lower levels of reduced glutathione (Someya
et al., 2010). Importantly, both ROS and impaired glutathione
levels are linked to increased susceptibility to NIHL (Someyaolism 20, 1059–1068, December 2, 2014 ª2014 Elsevier Inc. 1063
Figure 4. WldS Mice Are Protected against NIHL in a SIRT3-Dependent Fashion
WT C57BL/6, WldSTg+/ C57BL/6, SIRT3/ C57BL/6, and WldSTg+/ ;SIRT3/ C57BL/6 animals were tested for hearing loss just prior to a 2 hr 90 dB noise
exposure, 24 hr after noise exposure, and 14 days after noise exposure. SIRT3 was necessary for WldS protection against NIHL for both transient and permanent
hearing losses. Statistical analysis was performed using a two-way ANOVA followed by a Bonferroni post-test (***p < 0.001). Error bars represent SD.
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exposure may account for the increased mitochondria-derived
ROS that is seen following acoustic trauma (Ohlemiller et al.,
1999). Thus, activation of SIRT3 by augmenting intracellular
NAD+ levels provides a mechanism to counteract this central
pathogenic mechanism in hearing loss.
The WldS allele ameliorates axonal degeneration in a variety
of neurodegenerative models (Kaneko et al., 2006; Sajadi
et al., 2004; Samsam et al., 2003). However, therapeutic strate-
gies that mimic WldS are currently unavailable. Administration of
NAD+ is not viable due to the poor solubility, cell impermeability,
and serum instability of this compound (Pitka¨nen, 1971). The
recent development of a synthetic method to produce NR at
quantity sufficient for administration to animals (Yang et al.,
2007) allows the testing of the physiologic effects of augmenting
intracellular NAD+ levels. Our finding that NR mimics the NIHL
resistance seen in WldS animals raises the possibility that NR
might also be useful for preventing axonal degeneration in other
disease models that exhibit responsiveness to WldS expression.
The data supporting the role of NAD+ in axon protection have
been inconsistent. Although WldS animals show delayed axon
degeneration for several weeks in a transection model (Conforti
et al., 2009), application of NAD+ to transected axons in culture
delays degeneration for only a few hours or days (Wang et al.,
2005) and requires millimolar concentrations. Additionally,
inconsistent results using cultured neurons have made it unclearFigure 5. Administration of NR Prevents NIHL in a SIRT3-Dependent F
NR was administered to C57BL/6 animals at 1,000 mg/kg by intraperitoneal inject
necessary for NR-mediated protection against transient hearing loss at 24 hr and
two-way ANOVA followed by a Bonferroni post-test (*p < 0.05, **p < 0.01, ***p <
1064 Cell Metabolism 20, 1059–1068, December 2, 2014 ª2014 Elsewhether NAD+ would function to inhibit axon degeneration in an-
imals. Poor bioavailability has prevented testing the role of NAD+
in animals using disease-relevant axon degeneration models.
Our data using NR demonstrate that NAD+ and an NAD+ target,
SIRT3, control axon degeneration in animals. It will be important
to perform thorough analysis of NR and SIRT3 in other forms of
axon degeneration in animals to define which of these can be
blocked by NR.
Although our data identify a NAD+/SIRT3 pathway that influ-
ences neurite degeneration, other pathways are also likely to
affect neurite degeneration. First, it is likely that other sirtuins
are activated by increased NAD+ levels and contribute to the
axon-protective effects of NAD+, possibly by enhancing SIRT3
transcription, as has been described for SIRT1 (Amat et al.,
2009). Additionally, transection axon injury results in a loss of
the axonal NAD+ biosynthetic enzyme NMNAT-2 (Gilley and
Coleman, 2010). This is expected to result in an increase in
NMN levels (Gilley and Coleman, 2010). Expression of WldS
may delay transection-induced degeneration by converting
this accumulated NMN to NAD+. However, in addition to the
loss of the protective effects of NAD+, loss of NMNAT-2 could
lead to the accumulation of NAD+ metabolic precursors that
may have their own, potentially toxic, effects in axons (Di
Stefano et al., 2014). NR could have direct protective effects
by being converted to mitochondrial NAD+ and subsequently
to mitochondrial NADPH, which is required to regenerateashion
ion twice daily for 5 days prior to a noise exposure of 90 dB for 2 hr. SIRT3 was
permanent hearing loss at 14 days. Statistical analysis was performed using a
0.001). Error bars represent SD.
vier Inc.
Figure 6. NR Prevents Neurite Retraction from Inner Hair Cells in a SIRT3-Dependent Manner
(A) Neurite retraction from inner hair cells is reduced following noise exposure in mice treated with NR. To determine whether NR treatment also reduced spiral
ganglia neurite degeneration, C57BL6 mice were treated for 5 days with NR (1,000 mg/kg by intraperitoneal injection, twice daily) or vehicle prior to noise
exposure. Cochlea were then harvested either 24 hr or 14 days after noise exposure, and neurite retraction from inner hair cells wasmeasured by staining with an
anti-NF200 antibody (red, spiral ganglia neurites) and actin (green, inner hair cells). DAPI staining (blue) was used to identify the nucleus of the inner hair cells,
which defines the base of these cells. Representative immunofluorescence staining is shown for control mice that were not exposed to noise, noise-exposed
mice treated with vehicle, noise-exposed mice treated with NR, and noise-exposed SIRT3/ mice treated with NR. Neurite retraction (indicated with a white
bracket) is seen in vehicle-treated mice both 24 hr and 14 days following noise exposure. Neurite retraction is considerably reduced in NR-treated mice at both
time points (the junction between the neurites and hair cells is indicated with a white arrow). The protective effect of NR against neurite retraction is lost in
SIRT3/ animals. This suggests that NR stabilizes spiral ganglia neurites and prevents their retraction following noise exposure in a SIRT3-dependent manner.
Scale bar, 25 mm.
(B) Quantification of results in (A). The distance between the tips of the spiral ganglia neurites to the nucleus at the base of the inner hair cell (IHC) wasmeasured to
determine the degree of neurite retraction. Reduced neurite retraction is seen in noise-exposed mice that were treated with NR compared to those treated with
vehicle alone. This reduction in neurite retraction is dependent on SIRT3. Shown are the average measurements obtained from a minimum of five cochlea from
three mice for each group. Statistical analysis was performed using a one-way ANOVA followed by t test (*p < 0.05, **p < 0.01). Error bars represent SD.
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NAD+ and Noise-Induced Hearing Lossreduced glutathione, a neuroprotective agent in NIHL (Bellomo
et al., 1987; Yamasoba et al., 1998). NR or NAD+ may also influ-
ence CNS auditory pathways. Lastly, axon protection mediated
by overexpression of NMNAT enzymes may be in part due to
chaperone-like functions of these proteins. This activity may
contribute to their axon-protective effects in addition to their
NAD+ biosynthetic function (Zhai et al., 2008). Nevertheless,
our data suggest that NR mediates its effects through SIRT3
to induce substantial protective effects even in the absence of
these additional mechanisms.
It is currently unclear why there are marked person-to-person
differences in susceptibility to NIHL (Davis et al., 2003). Polymor-
phisms exist in the SIRT3 gene that affects its activity (Hirschey
et al., 2011) and may in turn contribute to susceptibility to NIHL.
NR is used as a dietary supplement and is a natural component
of milk and certain other foods (Bogan and Brenner, 2008),
raising the possibility that variability in dietary NR consumptionCell Metabcould also contribute to the susceptibility to hearing loss in
humans. Since NR exhibits minimal toxicity (Yang et al., 2007;
Bieganowski and Brenner, 2004; Canto´ et al., 2012), NR supple-
mentation may be a valuable approach for reducing the preva-
lence of NIHL.EXPERIMENTAL PROCEDURES
Chemicals
NR was synthesized as previously described (Yang et al., 2007). Other chem-
icals and reagents were purchased from Sigma except as indicated below.
Animals
Eight- to ten-week-old animals were used for all experiments to eliminate the
effects of aging in C57BL/6 animal backgrounds as previously described
(Someya et al., 2010). C57BL/6, BalbC, and CBA mice were purchased
from Jackson Laboratories. WldS tg/+ mice were provided backcrossed on a
C57BL/6 background and were further backcrossed a minimum of fiveolism 20, 1059–1068, December 2, 2014 ª2014 Elsevier Inc. 1065
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NAD+ and Noise-Induced Hearing Lossgenerations on the C57BL/6 background (Jackson Laboratories). These mice
were a kind gift of Dr. Michael Coleman (Babraham Institute, University of
Cambridge).
For experiments using SIRT3 knockout mice, male and female SIRT3/
mice were purchased from theMutant Mouse Resource Centers at the Univer-
sity of North Carolina-Chapel Hill (Chapel Hill, NC). These mice were devel-
oped from embryonic stem cells (ESCs) (Omni bank number OST341297)
with a retroviral promoter trap that functionally inactivates one allele of the
SIRT3 gene. SIRT3/ mice were backcrossed five generations onto the
C57BL/6 background.
The transgene SIRT3-overexpressing vector was constructed by intro-
ducing a C-terminal FLAGed cDNA encoding the mouse mitochondrial form
of SIRT3 (Cooper et al., 2009) into the pCall2 vector (Lobe et al., 1999). The
vector pCall2-mSIRT3 was double digested with XmnI and SfiI, and the result-
ing 7.9 kb fragment was gel purified and used to microinject C57BL/6 mouse
embryos oocytes (Gladstone Transgenic Gene-Targeting Core). Several inde-
pendent mouse lines carrying the SIRT3 transgene were generated. First-gen-
eration offspring (F1) of the injected mice were crossed with wild-type mice
and analyzed for germline incorporation of the transgene. Several F1 mice
with germline incorporation were preserved as founding SIRT3 transgenic
mouse lines. The mouse line used in this manuscript is called line 28 and con-
tains the transgene inserted in an intergenic region on chromosome 10 (NCBI
Ref NT_039500.7).
All animal behavioral studies were conducted at the AAALAC-approved
facility atWeill Cornell Medical College. Experiments were performed in accor-
dance with protocols approved by the Weill Cornell Medical College Institu-
tional Animal Care and Use Committee (New York, NY).
Cochlear Histology/Immunohistology
Mouse cochlea were prepared as previously described (Whitlon et al., 2001).
Briefly, mouse cochlea were quickly dissected from the temporal bone
following rapid decapitation. Once separated, the apex of the cochlea was
gently fenestrated, and the cochlea were immediately fixed in 4% paraformal-
dehyde overnight at 4C. The cochlea were then washed with three changes of
PBS and incubated in a decalcification solution (10% EDTA/PBS [pH 7.4]) un-
der constant rotation at 4C for 7 days. Decalcification solution was changed
daily. Cochlea were then washed in three changes of PBS and then treated
with progressively increasing sucrose concentrations from 10%–30%. They
were then incubated overnight in 30% sucrose at 4C. The cochlea were
then incubated an additional 24 hr in OCT compound (Tissue-Tek). Following
this final incubation the cochlea were transferred to cryomolds, carefully align-
ing the modiolus parallel to the bottom of the mold and frozen over dry ice.
Midmodiolar samples were then cut at a 10 mm thickness and mounted on
glass slides (VWR superfrost plus). Sections were then dried for 2 hr prior to
staining.
Slides were then postfixed with 1.5% paraformaldehyde for 5 min. Slides
were washed and then incubated with 0.5% Triton X-100/PBS for 15 min.
They were again washed and then blocked with 2% BSA/PBS. Sections
were then incubated with phalloidin-488 (Invitrogen) as per the manufac-
turer’s instructions for 20 min. Slides were washed and then incubated
with 1:1,000 rabbit anti-heavy neurofilament antibody overnight at 4C.
Slides were then washed and incubated with 1:1,000 Alexa Fluor 546
goat anti-rabbit antibody (Invitrogen) for 1 hr at room temperature. After a
final wash, sections were mounted with ProLong Gold antifade reagent
with DAPI (Life Technologies). Three-color epifluorescence imaging was
then performed using a Nikon Eclipse Ti microscope with a Coolsnap HQ2
camera.
NAD+ Quantification
Mice were injected twice daily with NR (1,000 mg/kg) for 5 days prior to noise
and injury and for 48 hr thereafter until they were sacrificed and cochlea har-
vested. Noise injury was performed as indicated below. Cochlea were isolated
by microdissection from the otic capsule. Pairs of cochlea were homogenized
with a micropestle and resuspended in 7% perchloric acid. Samples were
incubated for 5 min on ice, and any remaining insoluble debris was pelleted
and saved for protein quantification via bicinchoninic acid (BCA) assay. The
supernatant was neutralized (pH 7) with NaOH and 0.1 M phosphate buffer.
Sample was added to a 96-well plate and mixed with cycling assay buffer1066 Cell Metabolism 20, 1059–1068, December 2, 2014 ª2014 Else(5 mM Tris-HCl, 5 mM MgCl2, 50 mM KCl, 54 M resazurin, 2.25 mM lactate,
0.4 U/mL lactate dehydrogenase). Finally, 0.5 U diaphorase was added to
each well, and the production of resorufin was recorded (530 nm excitation,
580 nm emission) every 30 s for 15 min. NAD+ concentration was calculated
based on a standard curve, and the results were expressed as nmol NAD+
per mg of protein. Three technical replicates were performed for n = 7 mice
per condition. Because of experiment-to-experiment variation in sample pro-
cessing, samples were processed in parallel and normalized to the before-
noise sample. The normalized values from each experiment were used to
obtain the presented average values.
Auditory Testing
ABR testing was performed as previously described (Willott, 2006). Animals
were tested following sedation with ketamine/xylazine (40 mg/kg and
10 mg/kg, respectively). Tone burst stimuli at 8,000, 16,000, and 32,000 kHz
for 5 ms were used to elicit auditory evoked responses using an auditory
brainstem recording system (Intelligent Hearing Systems, Miami, FL). An
evoked response was determined by identifying waveforms at proper
time intervals that grew increased in magnitude with increasing volume as
described previously (Willott, 2006).
Noise Exposure
Animals were exposed to a 90 dB octave band for 2 hr in a cage placed in
a soundproof chamber (MAC-2, Industrial Acoustics Company, Bronx NY).
The mice were able to freely move throughout the cage. The octave band
was generated using ToneGen software (NCH software, Greenwood Village,
CO) routed through an Audiosource Amp100 amplifier driving two down-facing
Fostex FT-96H speakers. The sound pressure level was confirmed at 0, 30, 60,
and 90 min, and again just prior to completion of sound exposure using an
Extech microphone 407736.
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